Purchase Order 75N95023P00864
Award Date
9/20/23
Potential Completion Date
1/19/24
Potential Value
$190K
Funding Federal Agency
National Institute on Aging
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Fujirebio US, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Malvern, PA 19355, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute on Aging (NIA) awarded a $97,757.34 firm fixed-price purchase order to Fujirebio US, Inc. to provide assay kits for the Lumipulse G1200 instrument. The purpose is to leverage existing data on neuroimaging, cognitive, and clinical factors to understand cognitive and brain changes in healthy individuals and those with comorbidities. The original sources sought notice indicated the government was looking to acquire state-of-the-art assay kits for quantification of...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $107,238.60 firm fixed price purchase order to Quanterix Corporation, a for-profit manufacturer, for Simoa 4-plex 96-well plate assays to quantify serum/plasma biomarkers for Alzheimer's disease research. The assays will be used to analyze samples from participants in the Baltimore Longitudinal Study of Aging and the Genetic and Epigenetic Signatures of Translational Aging Laboratory...
This federal contract award was issued by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Fujirebio US, Inc., a foreign-owned, for-profit manufacturer of medical diagnostics equipment and reagents. The $3,949.61 firm fixed-price purchase order is for the delivery of enzyme immunoassays for the quantitative determination of tau protein in human cerebrospinal fluid (CSF). The contract does not have a...
This is a firm-fixed-price purchase order award to Alamar Biosciences, Inc. by the National Institute on Aging (NIA), a civilian agency, for $247,000.00. The contract is for providing proteomic analysis services, including the NULISAseq CNS Disease Panel 120 assay, next-generation sequencing, and bioinformatic support for 1,118 plasma samples. The purpose is to identify biomarkers that can be used to classify and stage Alzheimer's disease. This award is not associated with a set-aside and is the...
This firm fixed-price purchase order was awarded by the National Institute on Aging, a civilian agency, to Quanterix Corporation for an assay kit to quantify serum/plasma levels of Abeta40, Abeta 42, GFAP, and NF-light using a Simoa 4-plex assay. The $176,152.50 contract supports research on cognitive resilience and impairment, including for Alzheimer's disease, under the Baltimore Longitudinal Study of Aging. This requirement did not utilize any set-asides. Quanterix, a for-profit manufacturer,...
This is a $32,000 firm fixed price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Fujirebio US, Inc., a foreign-owned, for-profit manufacturer of medical diagnostics equipment and reagents. The award is for the purchase of a LUMIPULSE G1200 automated immunoassay instrument, which will be used in NIAID's Laboratory of Infectious Disease. The purchase was made through a full and open...
The Department of Health and Human Services' National Institutes of Health National Institute on Aging awarded Olink Proteomics Inc. a $74,130.04 firm fixed price purchase order to deliver EXPLORE 3072 REAGENT KITS. Performance will take place in Isveç, Turkey from July 25, 2023 through September 25, 2023. The National Institute on Aging supports biomedical research on the aging process and age-related diseases to promote the health and well-being of older adults. This purchase order for reagent...
This is a firm-fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency, to Alamar Biosciences, Inc. for the ALAMAR NULISASEQ INFLAMMATION PANEL 250 REAGENTS. The contract has a ceiling value of $324,000.00 and a period of performance through July 7, 2025. Alamar Biosciences, Inc. is a for-profit manufacturer of specialized biomedical research tools and services, with a focus on diagnostic technologies for central nervous system disorders like...
This non-competitive purchase order for $197,979.19 was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Aging to Quanterix Corporation of Billerica, Massachusetts. The firm fixed price order is for the purchase of Quanterix assay kits including the Neurology 3-Plex A Advantage Kit, pTau-181 Advantage Kit, P-Tau 231 Simoa Assay Kit, discs, buffers, and sealing oil to be used with the Simoa HD-X Analyzer currently owned by NIA. The...
This $1,786,400.00 firm fixed price purchase order contract was awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Amprion, Inc., a for-profit company specializing in neurological diagnostic services. The contract is for protein analysis services focused on detecting alpha-synuclein aggregates in cerebrospinal fluid samples, utilizing Amprion's proprietary SYNTap assay technology. The contract has a period of...